FDA Audits Of Supplement, OTC AERs Likely Starting This Year – Consultant
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement and OTC drug companies should not become accustomed to the "honeymoon" FDA has allowed from adverse event reporting compliance audits, according to Rick Kingston, an executive with SafetyCall adverse event reporting call center